BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $4.66 billion. The enterprise value is $5.87 billion.

Market Cap	4.66B
Enterprise Value	5.87B

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

BBIO has 187.13 million shares outstanding. The number of shares has increased by 17.07% in one year.

Shares Outstanding	187.13M
Shares Change (YoY)	+17.07%
Shares Change (QoQ)	+2.41%
Owned by Insiders (%)	5.24%
Owned by Institutions (%)	94.96%
Float	121.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.32
Forward PS	16.90
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	26.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.54

Current Ratio	5.54
Quick Ratio	5.34
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.36

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-84.30%
Return on Capital (ROIC)	-69.40%
Revenue Per Employee	$397,449
Profits Per Employee	-$978,658
Employee Count	550
Asset Turnover	0.34
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.57% in the last 52 weeks. The beta is 1.08, so BBIO's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	+43.57%
50-Day Moving Average	27.27
200-Day Moving Average	30.20
Relative Strength Index (RSI)	41.73
Average Volume (20 Days)	2,884,231

Short Selling Information

The latest short interest is 16.66 million, so 8.90% of the outstanding shares have been sold short.

Short Interest	16.66M
Short Previous Month	16.63M
Short % of Shares Out	8.90%
Short % of Float	13.75%
Short Ratio (days to cover)	9.97

Income Statement

In the last 12 months, BBIO had revenue of $218.60 million and -$538.26 million in losses. Loss per share was -$3.22.

Revenue	218.60M
Gross Profit	216.20M
Operating Income	-471.38M
Pretax Income	-538.26M
Net Income	-538.26M
EBITDA	-443.10M
EBIT	-453.62M
Loss Per Share	-$3.22

Full Income Statement

Balance Sheet

The company has $519.82 million in cash and $1.73 billion in debt, giving a net cash position of -$1.21 billion or -$6.46 per share.

Cash & Cash Equivalents	519.82M
Total Debt	1.73B
Net Cash	-1.21B
Net Cash Per Share	-$6.46
Equity (Book Value)	-1.05B
Book Value Per Share	-5.61
Working Capital	641.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$602.94 million and capital expenditures -$1.99 million, giving a free cash flow of -$604.92 million.

Operating Cash Flow	-602.94M
Capital Expenditures	-1.99M
Free Cash Flow	-604.92M
FCF Per Share	-$3.39

Full Cash Flow Statement

Margins

Gross margin is 98.91%, with operating and profit margins of -215.64% and -246.23%.

Gross Margin	98.91%
Operating Margin	-215.64%
Pretax Margin	-246.23%
Profit Margin	-246.23%
EBITDA Margin	-202.70%
EBIT Margin	-207.52%
FCF Margin	-276.73%

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.07%
Shareholder Yield	-17.07%
Earnings Yield	-11.55%
FCF Yield	-12.98%

Dividend Details

Analyst Forecast

The average price target for BBIO is $46.83, which is 88.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.83
Price Target Difference	88.00%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	189.20%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BBIO has an Altman Z-Score of -3.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.39
Piotroski F-Score	3